Keywords: عامل انعقاد XII; coagulation factor XI; hemostasis; contact activation pathway; bleeding; hemophilia C; coagulation factor XII
مقالات ISI عامل انعقاد XII (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
A missense mutation in the plasminogen gene, within the plasminogen kringle 3 domain, in hereditary angioedema with normal C1 inhibitor
Keywords: عامل انعقاد XII; Hereditary angioedema; Plasminogen; Kringle domain; C1 inhibitor; Coagulation factor XII; Missense mutation;
Hereditary Angioedema with Normal C1 Inhibitor and F12 Mutations in 42 Brazilian Families
Keywords: عامل انعقاد XII; Hereditary angioedema; Normal C1 inhibitor; F12 mutations; Estrogen; Brazilian population; ACEI; Angiotensin-converting enzyme inhibitor; C1-INH; C1 inhibitor; C1-INH-HAE; Hereditary angioedema with C1 inhibitor deficiency; eOC; Estrogen-containing oral c
Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema
Keywords: عامل انعقاد XII; Hereditary angioedema; angiopoietin-1; gene; mutation; multimers; tunica interna endothelial cell kinase 2 receptor; ANGPT1; Angiopoietin-1; ANGPT2; Angiopoietin-2; C1-INH; C1 inhibitor; C1-INH-HAE; Hereditary angioedema caused by C1 inhibitor deficiency;
Factor XII in coagulation, inflammation and beyond
Keywords: عامل انعقاد XII; Coagulation factor XII; Intrinsic blood coagulation; Kallikrein-kinin system; Bradykinin; B1; bradykinin receptor 1; B2; bradykinin receptor 2; BK; bradykinin; C1INH; C1 esterase inhibitor.; cAMP; cyclic adenosine monophosphate; CK1; cytokeratin 1; DXS; d
FXII promotes proteolytic processing of the LRP1 ectodomain
Keywords: عامل انعقاد XII; Coagulation factor XII; Low-density lipoprotein receptor-related protein 1; Extracellular proteolysis;
The role of activated coagulation factor XII in overall clot stability and fibrinolysis
Keywords: عامل انعقاد XII; Fibrinolysis; Tissue plasminogen activator (tPA); Fibrin(ogen); Coagulation factor XII; Blood coagulation; Clot structure;
C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema
Keywords: عامل انعقاد XII; BSA; bovine serum albumin; C1-inh; complement C1 esterase inhibitor; C1PIV; in vivo sized C1-inh polymers; CPDA; citrate phosphate dextrose adenine; CPK; chromozyme PK; FXII; coagulation factor XII; FXIIa; activated FXII; dBSA; heat denatured BSA; HAE; he
ELISA for determination of total coagulation factor XII concentration in human plasma
Keywords: عامل انعقاد XII; 4-PL; 4-parameter nonlinear logistic curve fitting; ANCOVA; analysis of covariance; APlC; anti phospholipid syndrome; B; within-laboratory standard deviation; C1-inh; complement C1 esterase inhibitor; CV; coefficient of variation; ELISA; enzyme linked imm
Hereditary Angioedema with Normal C1 Inhibitor
Keywords: عامل انعقاد XII; Hereditary angioedema with normal C1 inhibitor; Hereditary angioedema type III; Coagulation factor XII; Kallikrein-kinin pathway; Mutations in the F12 gene;
Brief CommunicationA novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor
Keywords: عامل انعقاد XII; aPTT; Activated partial thromboplastin time; bp; Base pair(s); C1-INH; C1-esterase inhibitor; DNA; Deoxyribonucleic acid; FXII; Coagulation factor XII; FXIIa; Activated coagulation factor XII; F12; Coagulation factor 12 gene; HAE; Hereditary angioedema; H
The impact of selective and non-selective non-steroid anti-inflammatory drugs on secondary hemostasis in healthy volunteers
Keywords: عامل انعقاد XII; COX–2 inhibitors; NSAID; Secondary hemostasis; Coagulation factor XII
Hereditary Angioedema with Normal C1 Inhibitor: Clinical Symptoms and Course
Keywords: عامل انعقاد XII; Angioedema; Hereditary Angioedema; Hereditary Angioedema Type III; Coagulation Factor XII; F12 Gene Mutations; C1 Inhibitor Deficiency